Akinetic Crisis in Parkinson’s Disease Following the Withdrawal of Continuous Subcutaneous Foslevodopa-Foscarbidopa Infusion: A Case Report
Year: 2026
Type: article
Study design: Case Report
Abstract: Akinetic crisis (AC) in Parkinson's disease (PD) is a life-threatening complication precipitated by abrupt changes or the impaired absorption of dopaminergic medication. We report a case of AC precipitated by an unintended suspension of continuous subcutaneous foslevodopa-foscarbidopa infusion (CSFLI) in a patient with advanced PD in a perioperative setting. Our observations highlight that despite its reputation as a reliable device-aided therapy (DAT), CSFLI remains vulnerable to abrupt interruptions and it may entail an under-recognized risk of AC. This case underscores the need for alternative dopaminergic routes, careful perioperative planning, and multidisciplinary collaboration in managing patients with advanced PD undergoing DAT.
Source: Internal Medicine
Language: English
Subfield: Clinical Neurology
Field: Medicine
Domain: Health Sciences
Open Access status: diamond
OpenAlex ID: W7235960460
